← All companies
TDOC
Teladoc Health, Inc.
$6.68
+0.10 +1.52%
Key statistics
from XBRL data in SEC filingsMarket cap
$1.21B
Revenue (TTM)
$2.49B
Net income (TTM)
-$177M
EPS (TTM)
$-0.99
P/E ratio
—
Dividend yield
—
Free cash flow
$285M
Cash
$774M
Total assets
$2.76B
Gross margin
12.5%
52-week range
$4.40 – $9.89
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Director or officer change; Regulation FD disclosure
Aug 3, 2026
10-Q
Quarter ended 2026-06-30
Jul 30, 2026
8-K
Results of operations (earnings release)
Jul 29, 2026
8-K
Shareholder vote results
May 21, 2026
10-Q
Quarter ended 2026-03-31
Apr 30, 2026
8-K
Results of operations (earnings release)
Apr 29, 2026
8-K
Director or officer change; Regulation FD disclosure
Mar 30, 2026
10-K
Fiscal year ended 2025-12-31
Feb 26, 2026
8-K
Results of operations (earnings release)
Feb 25, 2026
8-K
Director or officer change; Regulation FD disclosure
Feb 18, 2026
8-K
Director or officer change
Feb 12, 2026
8-K
Director or officer change
Dec 16, 2025
8-K
Director or officer change
Dec 12, 2025
10-Q
Quarter ended 2025-09-30
Oct 30, 2025
8-K
Results of operations (earnings release)
Oct 29, 2025
8-K
Results of operations (earnings release); Director or officer change; Regulation FD disclosure
Oct 23, 2025
10-Q
Quarter ended 2025-06-30
Jul 30, 2025
8-K
Results of operations (earnings release)
Jul 29, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
Jul 23, 2025
8-K
Director or officer change; Shareholder vote results
May 23, 2025
10-Q
Quarter ended 2025-03-31
May 1, 2025
8-K
Results of operations (earnings release)
Apr 30, 2025
10-K
Fiscal year ended 2024-12-31
Feb 27, 2025
8-K
Results of operations (earnings release)
Feb 26, 2025
10-Q
Quarter ended 2024-09-30
Oct 31, 2024
8-K
Results of operations (earnings release)
Oct 30, 2024
8-K
Director or officer change
Oct 1, 2024
8-K
Director or officer change
Sep 9, 2024
10-Q
Quarter ended 2024-06-30
Aug 1, 2024
8-K
Results of operations (earnings release)
Jul 31, 2024
8-K
Director or officer change
Jul 5, 2024
8-K
Director or officer change; Regulation FD disclosure
Jun 10, 2024
8-K
Shareholder vote results
May 24, 2024
10-Q
Quarter ended 2024-03-31
Apr 26, 2024
8-K
Results of operations (earnings release)
Apr 25, 2024
8-K
Director or officer change
Apr 12, 2024
8-K
Results of operations (earnings release); Director or officer change; Regulation FD disclosure
Apr 5, 2024
10-K
Fiscal year ended 2023-12-31
Feb 23, 2024
8-K
Results of operations (earnings release)
Feb 20, 2024
8-K
Director or officer change
Nov 14, 2023